ARCHIVES

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

NIH Director Zerhouni to discuss Roadmap initiatives Feb. 27.

February 20, 2004

Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair

September 19, 2014